In vitro antibacterial activity of KP-736, a new cephem antibiotic.
AUTOR(ES)
Maejima, T
RESUMO
KP-736, a new cephen antibiotic with a broad antibacterial spectrum and potent antipseudomonal activity, was evaluated for in vitro antibacterial activity in comparison with ceftazidime, cefotaxime, and cefpirome. KP-736 was significantly more active than the test compounds against gram-negative bacteria, including the Pseudomonas group and ceftazidime-, cefotaxime-, or imipenem-resistant strains, but less active against gram-positive bacteria. KP-736 had very high affinities for penicillin-binding protein 3 (PBP 3) of Escherichia coli K-12 and PBP 1A and PBP 3 of Pseudomonas aerugiosa NCTC 10490 and showed potent bactericidal activities against these two strains. It was stable to hydrolysis by penicillinases and cephalosporinases but was slightly hydrolyzed by oxyiminocephalosporinases and type II penicillinase.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=244949Documentos Relacionados
- In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.
- Maridomycin, a New Macrolide Antibiotic. In Vitro Antibacterial Activity of 9-Propionylmaridomycin
- In vitro antibacterial activity of faeriefungin, a new broad-spectrum polyene macrolide antibiotic.
- In vitro and in vivo antibacterial activity of KW1070, a new aminoglycoside antibiotic.
- In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.
